Subsys
Insys Therapeutics files for bankruptcy
June 11, 2019Manufacturing and Production DoJ, Subsys, bankruptcy, insys, pharma
Opioid drugmaker Insys Therapeutics has filed for Chapter 11 bankruptcy protection after agreeing to pay $225 million to settle charges …
Insys Therapeutics founder John Kapoor found guilty of bribing doctors
May 3, 2019Medical Communications Insys Therapeutics, John Kapoor, Subsys, fentanyl, opioid crisis, opioids, pharma
The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …
Insys Therapeutics names current CFO Andrew Long as company’s new CEO
April 16, 2019Manufacturing and Production CEO, Insys Therapeutics, Subsys, appointments, cfo, pharma
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …
Insys Therapeutics reaches $150m agreement to settle opioid marketing case
August 9, 2018Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma
The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …
Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl
October 27, 2017Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids
John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …
Insys Therapeutics sees revenue from Subsys at $61-$62 million; shares plunge 21%
April 11, 2016Business Services, Manufacturing and Production, Sales and Marketing Insys Therapeutics, Stock Price, Subsys, opioids, pain drug
Insys Therapeutics Inc (Nasdaq: INSY) stock plunged nearly 21% Monday after the company said sales for its pain drug will …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
